je.st
news
Home
› Abide Therapeutics Announces Strategic Drug Discovery Collaboration With Celgene Corporation To Advance Treatment Paradigm For Patients With Immune Disorders
Abide Therapeutics Announces Strategic Drug Discovery Collaboration With Celgene Corporation To Advance Treatment Paradigm For Patients With Immune Disorders
2014-03-05 05:21:55| drugdiscoveryonline Home Page
Abide Therapeutics today announced it has entered into a strategic collaboration with Celgene Corporation to discover and develop new drugs in inflammation and immunology
Tags: with
corporation
treatment
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||